Allozymes’ Post

Recently, I've already described the investment priorities https://lnkd.in/esGzfwaV of Rahim Invest FO 🇨🇭 and emphasized our focus on #MedTech and #BioTech including diversified #longevity technologies. Our clients, primarily #familyoffices from the #Gulfregion typically invest in Series A and B rounds, with co-investment checks ranging from $5 million to $80 million. In most cases, I don't meet with startups for pitches because our scouting and analytics team follows an approved and structured process for venture selection. My participation occurs only in the final stages of pipeline composition. However, BioTech and longevity technologies hold a special place in our scientific and investment specialization, so every team member must stay updated on this #DeepTech stack. Today, I was pleased to host Natalia Zhilinskaya COO of NanThermix SA and discuss their promising technology, which provides access to intracellular thermodynamics at the nanoscale. This is a fundamental scientific research area, and while it is too early-stage for our investors, I recommend #seedround #investors pay attention to NanThermix SA. This technology aligns with a critical global agenda and offers market potential and IRR that exceed many other trending DeepTech streams, comparable with the long-term potential of investments in AI. However, the main challenge for seed-round investors is the high level of risk. The key indicators of #earlystage #startups in high-demand markets include experienced and successful teams and a seasoned entrepreneur as the founder. Andrey Sinogeykin the founder of NanThermix SA, has over 20 years of a successful track record in investing in early-stage DeepTech startups and managing various businesses. Additionally, NanThermix SA is based in #Lausanne #Switzerland one of the most credible and impressive international BioTech hubs #EPFL The high-speed scientific progress in this hub accelerates the development of BioTech and MedTech research, enabling faster conversion from fundamental patents to industrial implementation. If my post has raised any professional investment questions, please DM Natalia Zhilinskaya.

Latvian #biotech Cellbox Labs, which develops #industrial organ-on-chip technology, has raised €935K in a pre-seed round, led by Latvian Buildit VC, with participation from a syndicate of 12 LatBAN’s angels, managed by Girts Licis, Latvian investment fund ASP Asset Management AIFP, and its owner Ansis Spridzans. Founded in 2020 in #Riga by Arturs Abols, Gatis Mozolevskis, and Roberts Rimša, Cellbox Labs develops an organ-on-chip technology, which is based on the creation of miniature replicas of human organs (gut, lung) outside of the human organism, thus reducing animal testing in #research. These replicas can be used to test various biological processes and for drug development. This technology allows for more accurate predictions of a drug's efficacy and toxicity during the development phase. Additionally, Cellbox Labs is developing an automated organ-on-chip cultivation device that ensures high productivity, reduces the impact of human error, and minimizes the need for manual intervention. The startup will use the investment to complete the first version of this device and begin sales. Buildit is an accelerator for hardware and IoT startups. It provides €10K to €50K of pre-seed investments to best-performing startups and up to €250K of seed investments. Buildit's partners are Matiss Neimanis, Rene Tõnnisson, and Aleksander Tõnnisson. Read more https://lnkd.in/ekMDDUEn #Latvia #startup #startups #tech #technology #technologies #TechnologyNews #TechNews #Deal #Deals #VentureCapital #VC #MedTech

Took part in Industrial Exchange and Investment Environment meeting at The Royal Society and Futian Industry & Investment Exchange seminar for #scientists #startups #business #academics #commercialization #shenzhen #futian #cooperation #investments today. Great pleasure and results for academics and business connections, starting new cooperation for the main research challenges in 3d bioprinting and other #biotech and #medtech topics. Glad that EI Consulting (UK) https://eiconsulting.tech expertise is useful. Great potential for #startups #biotech #medtech in #a1000 https://a1000.tech pipeline and for UK-China Scientific, Industrial and Investment Exchange. More to come.

"Noticing an absence of a common language and an effective network in the field, this report aims to facilitate cross-pollination across borders by providing a multi-perspective roadmap and an action guide in nature-inspired innovation from initial ideas to reality." - Biomimicry Innovation Lab & Nadathur Group Read more: https://lnkd.in/ezFHkfcv #natureinspiredinnovation #biomimetic #bionics #innovation #biomimicry #investment #startup #spinout #scaleup #uk #unitedkingdom "Hi, we're Biomimicry Innovation Lab. We partner with founders and leaders to transform ideas into reality, drawing inspiration from transformative solutions found in nature. Our approach? Harnessing the latest scientific research with innovative tools to deliver solutions to complex challenges. Follow us to explore the power of nature-inspired innovation or reach out to dive deeper!"

🚨 Final Call for Bio10x Accelerator Applications! 🚨 Attention #biotech innovators across Australia! The Bio10x Accelerator is now offering six startups $70k in total #funding —$50k from Proto Axiom and $20k from #UNSW. Additionally, eligible startups can access $30k vouchers from Bioplatforms Australia. We are specifically seeking startups, ideally spun out from any university in #Australia, with IP assignments completed and option agreements signed and finalised by both parties. This ensures you're ready to hit the ground running with commercialising your #innovation. This comprehensive support package includes access to #PC2labs and unlimited #mentoring from industry #experts at UNSW Founders. Leverage these resources to overcome crucial R&D, IP, and regulatory milestones. 📅 Applications close in a little over 24 hours — May 30th, 5 PM. Apply now and take the first step towards accelerating your biotech venture!  https://lnkd.in/g2-Wc_fF **This program is open Australia-wide, with no UNSW affiliation required. For inquiries, contact Maddison McCoy, Program Manager. #spinouts #commercialisation #australianresearchers #biotechnology

💼 Deal Snaps Weekly Review 💼 This week in the world of startups, we witnessed some remarkable deals that are shaping the landscape. Here's a quick roundup: 👟 Sneaker marketplace Novelship secures $9.5 million in series B funding led by East Ventures. 👩🏻🌾 Singaporean farming firm RegenX secures $500k in pre-seed funding round led by Wavemaker Impact. 🌾 Agritech firm Koltiva secures series A funding round led by AC Ventures. 🔩 Raw materials platform Bababos secures $3 million in seed funding round led by East Ventures. 🧬 Generic testing company Gene Solutions raises $21 million in series B funding round led by Mekong Capital. 🧪 Biotechnology startup Automera secures $16 million in series A funding round jointly led by Accelerator Life Science Partners (ASLP) & ClavystBio. 🔍 Discover deals daily at https://lnkd.in/geQ_vcm6. #StartupDeals #Fundraising

𝗬𝗼𝘂 𝗵𝗮𝘃𝗲 𝗼𝗻𝗹𝘆 𝘁𝘄𝗼 𝗺𝗼𝗿𝗲 𝘄𝗲𝗲𝗸𝘀 𝘁𝗼 𝗮𝗽𝗽𝗹𝘆 𝘁𝗼 𝗙𝗿𝗼𝗺 𝗟𝗮𝗯 𝘁𝗼 𝗠𝗮𝗿𝗸𝗲𝘁 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲! That being said, we would like to remind you again why participating in our idea competition is a great opportunity: 👀 View your research from another angle 🤝 Make connections with like-minded scientists who consider taking their research to market as well as industry experts and capital specialists 🧑🔬 Make major progress like teams which participated in the last two years, ChemInnovation, Octo Germany, Alteva Technologies, MechSyn and ChitoNExt, teams which have successfully secured funding to found their companies. Participate by filling out the form on our website, link in the comments. 🚀 #startup #futurefounders #chemistry #biotech

The proposal of SPRIND (German Agency for Disruptive Innovations) to license IP for virtual shares as a standard procedure for start-ups has not met with universal approval. How applicable is such a model to biotechnology start-ups, and can a one-size-fits-all approach really do away with defining market value and negotiating fair and reasonable IP terms? After a keynote, representatives of SPRIND, universities and technology transfer experts will share their experience and discuss their various approaches to start-up creation.   We look forward to the contributions to the panel from Birgit Kerber from and Thomas Hanke and the presentations by: Regina Hodits from Wellington Partners Nicolas Krink from SPRIND - Bundesagentur für Sprunginnovationen Dr. Andrea Schmoll from Osborne Clarke Rainer Wessel from DKFZ Deutsches Krebsforschungszentrum   #IP #Startups #Biotechnology #SPRIND #Technology #Biotech #DBT2024

The Hong Kong Exchanges and Clearing (#HKEX) will hold the HKEX #Biotech Summit 2023 on Sep 5 (Tue). The Biotech Summit will bring together industry experts, scientists, executives, and investors from across the world to discuss the latest developments that are shaping the global #healthcare industry, with a particular focus on Asia. Register here: https://shorturl.at/yCGL7 As Asia's largest #fundraising hub for #biotechnology, Hong Kong offers various #incubation programmes for #startups in strategic sectors. With close to 4,000 startups as of 2022, Hong Kong is the premier place in Asia to capitalise on ideas and drive innovation. Not only is Hong Kong’s government fostering its startup ecosystem for biotechnology companies, but the city will overtake the Nasdaq as the world’s largest biotech #funding hub in the next five to 10 years, according to the HKEX. Hong Kong is in line to become a hub for biotechnology research also. According to The Chinese University of Hong Kong’s award-winning Professor Dennis Lo Yuk-ming, Hong Kong has the right ingredients to set up a national-level #biomedical laboratory that would be endorsed by Beijing. This would elevate Hong Kong into becoming China’s global innovation and technology hub.  ---- Looking for opportunities as a startup or investor? Get in touch with us: https://lnkd.in/guMgSpw7 Subscribe to the StartmeupHK eNewsletter: https://lnkd.in/gRZuyXsQ #StartmeupHK #InvestHK #startups #HongKong #innovation #technology

Biotech Breakthroughs: It's Time to Level Up! 🔬 Biotech's been a beacon of progress, driving medical, food, and material revolutions. We are entering an era that is increasingly digital and data-rich, which is poised to redefine our comprehension of life itself. 🧬💻 As a biotech trailblazer, your focus should be on pioneering this change, not getting tangled in financial chores. At Stewart Robinson, we fuel your journey by handling those tasks, so you can shape the biotech future. Want to ride the biotech wave with Stewart Robinson's support? Click here. www.robinsoncpa.net Drop a comment on the one biotech innovation that excites you most for the future. Let's talk biotech! 📝 #biotech #startups #CFO #lifescience #biotechcpa